Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

2(40.0%)

N/A

2(40.0%)

Phase 1

1(20.0%)

5Total

Phase 2(2)

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06585982Not ApplicableRecruiting

Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis

Role: collaborator

NCT06044376Phase 1Unknown

Ingestion Effect of Formula Milk With Triple Bifidobacteria Strains on Fecal Quality and Metabolites in Healthy Children

Role: collaborator

NCT05849883Not ApplicableCompleted

Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject

Role: lead

NCT05067946Phase 2Withdrawn

Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines

Role: collaborator

NCT00319345Phase 2Terminated

Sodium-Lactate and Traumatic Brain Injury

Role: collaborator

All 5 trials loaded